Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Fast-acting mealtime insulin. | Fast-acting mealtime insulin. |
| Body system | Diabetes & Weight | Diabetes & Weight |
| Drug class | Insulins | Insulins |
| Supply | Prescription only | Prescription only |
| Main uses | Type 1 diabetes, Type 2 diabetes | Type 1 diabetes (mealtime and pumps), Type 2 diabetes needing mealtime insulin, Diabetic ketoacidosis (IV regimens use soluble insulin) |
| How it works | Replaces mealtime insulin so cells can use glucose for energy. | Works fast to cover the sugar from a meal. |
| Starts working | — | 10–20 minutes; peak 1–3 hours |
| Half-life | — | Duration 3–5 hours |
| Typical adult dose | Individualised and usually taken shortly before a meal; follow the prescribed carbohydrate and glucose plan. | Individual — given 0–15 minutes before meals, adjusted to carbohydrate intake. |
| Forms | Pre-filled pen, Cartridge, Vial | Pen injection, Vial, Pump cartridge |
| Common side effects | Low blood sugar, Injection-site reactions, Weight gain | Low blood sugar, Injection-site reactions |
| Serious side effects | Severe hypoglycaemia, Low potassium, Allergic reaction | Severe hypoglycaemia, Low potassium |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Generally considered safeRapid-acting insulin can be used in pregnancy when prescribed. | Generally considered safeUsed routinely in pregnancy. |
| Breastfeeding | — | — |
| In use since | — | 1999 |
| Brand names | United States: HumalogUnited Kingdom: Humalog | United States: NovoLog, FiaspUnited Kingdom: NovoRapid, FiaspIndia: NovoRapid |
| Legal status | — | — |
| ATC code | A10AB04 | A10AB05 |
Taken together
- MinorInsulin lispro + Insulin aspart: More risk of low blood sugar
Both medicines lower blood sugar; combinations are common but hypos become more likely.